Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
5,036
Total Claims
$597K
Drug Cost
460
Beneficiaries
$1,297
Cost/Patient
Risk Score Breakdown 49/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+1453%
Opioid rate vs peers
58.8% vs 3.8% avg
+10%
Cost per patient vs peers
$1,297 vs $1,174 avg
+42%
Brand preference vs peers
12.5% vs 8.9% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid prescribing rate is 1,453% above the average for Nurse Practitioner providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
58.8%
Opioid Rate
2,959
Opioid Claims
$268K
Opioid Cost
12.1%
Long-Acting Rate
This provider's opioid prescribing rate of 58.8% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 632 claims · $359K
Generic: 4,404 claims · $238K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Naloxegol Oxalate | 214 | $95K |
| Linaclotide | 137 | $94K |
| Oxycodone Myristate | 113 | $87K |
| Levorphanol Tartrate | 18 | $85K |
| Oxycodone Hcl/Acetaminophen | 1,748 | $68K |
| Oxycodone Hcl | 51 | $31K |
| Tapentadol Hcl | 12 | $19K |
| Hydrocodone/Acetaminophen | 590 | $19K |
| Lidocaine | 67 | $9,367 |
| Gabapentin | 415 | $5,881 |
| Pregabalin | 213 | $5,793 |
| Lubiprostone | 29 | $5,554 |
| Diclofenac Sodium | 77 | $5,252 |
| Tizanidine Hcl | 279 | $3,999 |
| Cyclobenzaprine Hcl | 255 | $3,186 |
Prescribing Profile
24
Unique Drugs
49.0
Anomaly Score
Patient Profile
65
Avg Age
67%
Female
1.90
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About